Rivus Pharmaceuticals
PrivateLast Round
Series B
Sep 22, 2022
Total Funding Raised
$167M
Company Overview
Rivus Pharmaceuticals is a biopharmaceutical company that develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health through oral small-molecule therapeutics targeting the root causes of metabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivus Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Rivus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 22, 2022 | ||||
| Series A | Jul 20, 2021 |
Key People
Founding team and executive leadership
Rivus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Bain Capital Life Sciences | Series B |
| RA Capital Management | Series B |
| BB Biotech | Series B |
| Medicxi | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2026
Allen Cunningham transitions to Chief Operating Officer.
- Feb 27, 2026
Co-founder Allen Cunningham moves to COO role.
Rivus Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rivus Pharmaceuticals's valuation, stock price, and market status.
